Clinical Trials Logo

Filter by:
NCT ID: NCT05229172 Completed - Clinical trials for Respiratory Insufficiency in Children

Fabian Prospective Assessment of Volume Guarantee (Fabian PaVoG)

PaVoG
Start date: February 24, 2022
Phase:
Study type: Observational

This study is planned as a part of the post market clinical follow-up (PMCF) on a CE marked product and will provide performance data on the Volume Guarantee function of the fabian ventilator in daily clinical routine.

NCT ID: NCT05225467 Completed - Diabetes Mellitus Clinical Trials

Development of Ketoacidosis During the Perioperative Period: an Observational Study 'The DKAP Study'

DKAP
Start date: March 15, 2022
Phase:
Study type: Observational [Patient Registry]

Rationale: During perioperative period, prolonged starvation, surgical stress, acute complications (e.g. infection) and medication changes all promote ketone generation, therefore increasing the risk of ketoacidosis. At present, there is no literature concerning the ketone production in patients undergoing cardiac surgery, regardless of the diabetes status. Objectives: The objectives of this study are to explore the change in blood ketone level during the perioperative period in patients with and without diabetes, to observe the incidence of perioperative ketoacidosis, and to investigate therapy and outcome of patients with perioperative ketoacidosis.

NCT ID: NCT05224947 Completed - Infant Formula Clinical Trials

Gastric Layering and Monitoring II

GLAM-II
Start date: January 28, 2022
Phase: N/A
Study type: Interventional

Rationale: Results from a previous study suggest that gastric layer formation, which is caused by emulsion instability as a result of gastric acidification/digestion, is different between breastmilk and infant formula. The current study focusses on further understanding of these differences by investigating the effect of formula composition. Objective: To investigate the effect of infant formula composition on intragastric behavior, gastric emptying and postprandial plasma parameters. Study design: Double-blind cross-over study with two treatments. Study population: 20 healthy normal-weight males, aged 18-45 y. Intervention: After an overnight fast, participants will drink sufficient volume of one of the two IFs which differ in composition. Gastric content will be monitored using Magnetic Resonance Imaging (MRI). MRI scans will be done and blood samples will be taken for subsequent analyses at baseline and post prandially . Main study parameters/endpoints: The primary outcome is gastric behavior. Secondary outcomes are total gastric content volume over time and blood parameters. Nature and extent of the burden and risks associated with participation, benefit and group relatedness: The risks associated with participation are low, as both phlebotomy and MRI are eminently safe medical techniques. In addition, the test formula are safe. Each participant will participate in 2 sessions, which require an overnight fast, 9 blood withdrawals (in total 120 mL per visit) and multiple MRI scans over a period of approximately 2 hours. These measurements are non-invasive and carry minimal risk. The burden of the sessions is most likely related to mild discomfort as they have to lie still in the MRI for two hours. This will be minimized by the soft mattress on the bed of the MRI, leg rest and a pillow underneath the head.

NCT ID: NCT05221515 Completed - Clinical trials for Autism Spectrum Disorder

The Effectiveness of an Attention-based Intervention for School Aged Autistic Children With Anger Regulating Problems

Start date: January 1, 2011
Phase: N/A
Study type: Interventional

Children on the autism spectrum often show aggressive behavior. Treatment can train children to be more aware of their emotions. Investigators studied the effectiveness of an attention-based intervention tailored on aggressive behavior problems and the use of anger coping strategies of school aged autistic children with anger regulation problems.

NCT ID: NCT05219071 Completed - Clinical trials for Erectile Dysfunction

TRIP-Patch vs the Rigiscan

TRIP-Patch
Start date: June 20, 2022
Phase:
Study type: Observational

In men without erectile problems, night time erections occur during the REM-sleep. For this study the current diagnostic test, the Rigiscan is compared, with the data from the TRIP-Patch during the night. To validate discriminating sensor-readings between flaccid state and full rigidity of the penis. Eventually, to have a validated device, a patch in the size of a postage stamp, that easily measures erectile function at home. Furthermore the temperature on the outside of the thigh will be measured.

NCT ID: NCT05217433 Completed - Muscular Fatigue Clinical Trials

Oleuropein and Muscle Energy Metabolism

Start date: November 4, 2021
Phase: N/A
Study type: Interventional

Preclinical studies performed at Nestlé Research (NR) identified oleuropein as a novel activator of mitochondrial calcium import. This potentiated mitochondrial calcium uptake resulted in decreased phosphorylation of the enzyme pyruvate dehydrogenase (PDH), which is linked to its activation as a rate limiting enzyme for mitochondrial oxidation, as well as increasing mitochondrial oxygen consumption, resulting ultimately in decreases in muscle fatigue. In addition, NR demonstrated that during aging, mitochondrial calcium and oxygen consumption rates are decreased in isolated skeletal muscle fibers. The next step in the evidence development is to demonstrate efficacy of oleuropein for improved muscle energy and decreased physical fatigue in a healthy aging population.

NCT ID: NCT05215483 Completed - COVID-19 Clinical Trials

Availability and Advice on Test Uptake During the COVID-19 Pandemic: a Vignette Study.

Start date: November 11, 2021
Phase: N/A
Study type: Interventional

Lateral Flow Testing (LFT) use for COVID-19 related symptoms continues to rise, despite governmental advice to test at a test facility. In this study we investigate whether 1) adjusting the governmental testing advice will lead to a collective increase of people who test with COVID-19 symptoms and if this leads to a higher strategy sensitivity.

NCT ID: NCT05215210 Completed - Clinical trials for Impaired Glucose Tolerance

The Effect of Long-term Momordica Charantia Supplementation on Blood Glucose Levels

Bitter-Zoet 2
Start date: March 23, 2022
Phase: N/A
Study type: Interventional

The study is a parallel, double blind, controlled trial in which study participants will receive a 12-week intervention with 3.6 g/d dried bitter-gourd supplements or a reference intervention with 3.6 g/d dried cucumber supplements. Research subjects will come to the research facility for a test day on four occasions, with an interval of 4 weeks. The main study parameter is fasting levels of plasma glucose.

NCT ID: NCT05214625 Completed - Clinical trials for Gastro-Intestinal Disorders

Questionnaire Study Concerning Artificial Intelligence

Start date: April 8, 2020
Phase:
Study type: Observational

This study aims to investigate the knowledge, experience, and opinion on AI among gastroenterology (GI) patients, gastroenterologists, and GI-fellows, particularly concerning implementation and application of AI (in assisting clinicians) in healthcare. The secondary aims are to investigate (dis)advantages of AI use in healthcare and the availability of technical facilities and infrastructures within endoscopy to implement and apply AI in Dutch hospitals.

NCT ID: NCT05214287 Completed - Parkinson Disease Clinical Trials

Multiple N-of-1 Trials of (Intermittent) Hypoxia Therapy in Parkinson's Disease

TALISMAN
Start date: February 22, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

In recent years, mitochondrial dysfunction and oxidative stress have been implicated in PD pathophysiology. Intermittent hypoxia therapy (IHT) is an upcoming treatment used by elite athletes as well as fragile individuals in clinical settings that works by improving exercise tolerance, neuroplasticity and inducing hypoxic preconditioning (HPC). HPC might improve the oxidative stress response in PD on the long-term. In addition, preclinical evidence suggests beneficial short-term effects such as influence on dopamine and noradrenalin release. Anecdotal evidence indeed suggests that visiting high-altitude areas improves PD symptoms and it is hypothesized that this effect results from decreased oxygen pressure at high altitudes. The safety and feasibility of (intermittent) hypoxia therapy on PD symptoms will be assessed in an exploratory phase I randomized-controlled trial.